| # | Title | Journal | Year | Citations |
|---|
| 1 | Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease | Gastroenterology | 2002 | 379 |
| 2 | Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs | Gastroenterology | 2018 | 310 |
| 3 | HLA-DQA1–HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants | Nature Genetics | 2014 | 165 |
| 4 | Intestinal permeability in the pathogenesis of NSAID-induced enteropathy | Journal of Gastroenterology | 2009 | 130 |
| 5 | Assessing telephone-delivered cognitive–behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial | Gut | 2019 | 123 |
| 6 | Randomised clinical trial: a liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome - a 12 week double-blind study | Alimentary Pharmacology and Therapeutics | 2014 | 121 |
| 7 | An Atlas of Human Regulatory T Helper-like Cells Reveals Features of Th2-like Tregs that Support a Tumorigenic Environment | Cell Reports | 2017 | 118 |
| 8 | Systematic review: bile acids and intestinal inflammation‐luminal aggressors or regulators of mucosal defence? | Alimentary Pharmacology and Therapeutics | 2015 | 106 |
| 9 | COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study | The Lancet Gastroenterology and Hepatology | 2022 | 100 |
| 10 | Gastrointestinal toxicity of immune checkpoint inhibitors: from mechanisms to management | Nature Reviews Gastroenterology and Hepatology | 2018 | 82 |
| 11 | Gastrointestinal safety of NSAIDs and over-the-counter analgesics | International Journal of Clinical Practice | 2013 | 80 |
| 12 | Fecal M2-pyruvate kinase (M2-PK): A novel marker of intestinal inflammation | Inflammatory Bowel Diseases | 2007 | 74 |
| 13 | The impact of inflammatory bowel disease post‐liver transplantation for primary sclerosing cholangitis | Liver International | 2013 | 74 |
| 14 | Gastrointestinal dysfunction in Parkinson’s disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation | Journal of Neurology | 2022 | 63 |
| 15 | Rifaximin Reduces the Number and Severity of Intestinal Lesions Associated With Use of Nonsteroidal Anti-Inflammatory Drugs in Humans | Gastroenterology | 2017 | 57 |
| 16 | Significantly higher frequency of Helicobacter suis in patients with idiopathic parkinsonism than in control patients | Alimentary Pharmacology and Therapeutics | 2013 | 54 |
| 17 | A 4-strain probiotic supplement influences gut microbiota composition and gut wall function in patients with ulcerative colitis | International Journal of Pharmaceutics | 2020 | 51 |
| 18 | Adverse effects of drugs on small intestine and colon | Bailliere's Best Practice and Research in Clinical Gastroenterology | 2010 | 50 |
| 19 | Intestinal infection and irritable bowel syndrome | European Journal of Gastroenterology and Hepatology | 2005 | 47 |
| 20 | Selective white cell apheresis reduces relapse rates in patients with IBD at significant risk of clinical relapse | Inflammatory Bowel Diseases | 2008 | 45 |
| 21 | Impact of neuroendocrine morphology on cancer outcomes and stage at diagnosis: a UK nationwide cohort study 2013–2015 | British Journal of Cancer | 2019 | 44 |
| 22 | Peripheral aetiopathogenic drivers and mediators of Parkinson’s disease and co-morbidities: role of gastrointestinal microbiota | Journal of NeuroVirology | 2016 | 42 |
| 23 | Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial | Gut | 2022 | 37 |
| 24 | Neurogenic and anti-inflammatory effects of probiotics in Parkinson’s disease: A systematic review of preclinical and clinical evidence | Brain, Behavior, and Immunity | 2021 | 35 |
| 25 | Antimicrobial Surveillance in Idiopathic Parkinsonism: Indication‐Specific Improvement in Hypokinesia Following Helicobacter pylori Eradication and Non‐Specific Effect of Antimicrobials for Other Indications in Worsening Rigidity | Helicobacter | 2013 | 34 |
| 26 | Psychological approach to managing irritable bowel syndrome | BMJ: British Medical Journal | 2007 | 33 |
| 27 | British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitis | The Lancet Gastroenterology and Hepatology | 2020 | 33 |
| 28 | Assessing Cognitive behavioural Therapy in Irritable Bowel (ACTIB): protocol for a randomised controlled trial of clinical-effectiveness and cost-effectiveness of therapist delivered cognitive behavioural therapy and web-based self-management in irritable bowel syndrome in adults | BMJ Open | 2015 | 32 |
| 29 | Drug-Induced Small Bowel Injury: a Challenging and Often Forgotten Clinical Condition | Current Gastroenterology Reports | 2019 | 32 |
| 30 | Upper gastrointestinal endoscopy performed by nurses: scope for the future? | Gut | 2003 | 31 |
| 31 | COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study | The Lancet Gastroenterology and Hepatology | 2022 | 28 |
| 32 | Safety of Anti-TNF Treatment in Liver Transplant Recipients: A Systematic Review and Meta-analysis | Journal of Crohn's and Colitis | 2017 | 27 |
| 33 | Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT | Health Technology Assessment | 2019 | 27 |
| 34 | Blood profile holds clues to role of infection in a premonitory state for idiopathic parkinsonism and of gastrointestinal infection in established disease | Gut Pathogens | 2009 | 25 |
| 35 | Presenting Symptoms and Delay in Diagnosis of Gastrointestinal and Pancreatic Neuroendocrine Tumours | Neuroendocrinology | 2018 | 25 |
| 36 | Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis | EBioMedicine | 2015 | 20 |
| 37 | A qualitative study exploring the experience of people with IBD and elevated symptoms of anxiety and low mood and the type of psychological help they would like | Psychology and Health | 2018 | 20 |
| 38 | Faecal immunochemical testing in the COVID-19 era: balancing risk and costs | The Lancet Gastroenterology and Hepatology | 2020 | 20 |
| 39 | Hemostatic spray powder TC-325 in the primary endoscopic treatment of peptic ulcer-related bleeding: multicenter international registry | Endoscopy | 2021 | 20 |
| 40 | Climate Change and Gastroenterology: Planetary Primum Non Nocere and How Industry Must Help | American Journal of Gastroenterology | 2022 | 20 |
| 41 | Early change in faecal calprotectin predicts primary non-response to anti-TNFα therapy in Crohn’s disease | Scandinavian Journal of Gastroenterology | 2016 | 19 |
| 42 | Measurement of quality of life in carcinoid/neuroendocrine tumours. | Endocrine-Related Cancer | 2003 | 16 |
| 43 | Unexplained (non-cardiac) chest pain | Clinical Medicine | 2006 | 16 |
| 44 | Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force) | Journal of Neuroendocrinology | 2022 | 16 |
| 45 | Is local excision sufficient in selected grade 1 or 2 type III gastric neuroendocrine neoplasms? | Endocrine | 2021 | 15 |
| 46 | A novel isolation protocol and probe‐based RT‐PCR for diagnosis of gastric infections with the zoonotic pathogen Helicobacter suis | Helicobacter | 2017 | 14 |
| 47 | Ileocolonic neuroendocrine tumours identified in the English bowel cancer screening programme | Colorectal Disease | 2018 | 13 |
| 48 | Effectiveness and safety of vedolizumab in inflammatory bowel disease patients aged 60 and over: an observational multicenter UK experience | Annals of Gastroenterology | 2020 | 13 |
| 49 | Cognitive behaviour therapy for distress in people with inflammatory bowel disease: A benchmarking study | Clinical Psychology and Psychotherapy | 2019 | 12 |
| 50 | Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE | Journal of Nuclear Medicine | 2021 | 12 |
